Medical News

RSS

Social changes spawn massive resurgence of syphilis in China

Despite the virtual elimination of syphilis in China in the 1950s, the sexually transmitted infection is currently at epidemic proportions in the country and rates of infection will continue to grow unless a more comprehensive, coordinated effort of control is implemented, according to a perspective published in the May 6 issue of the New England Journal of Medicine.

6 May 2010

Advocates ask donor nations, African Governments to maintain health commitments as WEF on Africa starts

As the 2010 World Economic Forum on Africa begins Wednesday in Dar Es Salaam, Tanzania, advocates from more than 10 African countries plan to "stage a demonstration" highlighting the need for funding for HIV/AIDS and other diseases, health-e reports (Thom, 5/5).

6 May 2010

Cohera Medical reports top-line results from Tissuglu clinical trial

Cohera Medical, Inc.® today announced that top-line clinical study results demonstrate the safety and preliminary effectiveness of the company's lead surgical adhesive product, TissuGlu®.

6 May 2010

Sermo Category Report: About 30% of patients suffer from depression

Sermo, the world's largest online community for physicians, today announced a Sermo Category Report titled Antidepressant Treatment Behaviors. The report surveyed more than 200 primary care physicians and covers a variety of topics including product choice drivers, treatment paths, referring habits, and overall issues in depression management.

6 May 2010

Pharmasset reports net loss of $16.1 million for fiscal second-quarter 2010

Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.

6 May 2010

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

Intercell AG today announced that it has signed an agreement with Cytos Biotechnology Ltd. to acquire Cytos' platform technology for monoclonal antibody discovery. The technology is based on expression cloning of monoclonal antibodies from human B-cells and enables the identification of anti-infective antibodies to prevent and treat infectious diseases.

6 May 2010

FiatLux Imaging extends availability of free medical software

FiatLux Imaging, Inc., a company dedicated to the development of powerful and useful new software to make the practice of medicine more effective, less expensive and more timely, announced today that, due to user demand and rapidly expanding use, it is extending the free availability of its Visualize FREE application for reading and analyzing medical imaging studies.

6 May 2010

RayBiotech announces biomarker grant winners

RayBiotech, Inc. has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. Ray (Ruopan) Huang, Founder and President of RayBiotech, "we intend to demonstrate that any researcher with a modest research budget can successfully discover and validate disease-related biomarkers using our antibody arrays."

6 May 2010

Opinions: G8's track record; Maternal, child health; Chan on N. Korea; USAID, DDT in Haiti

In a Vancouver Sun opinion piece, columnist Barbara Yaffe writes about the "disappointing track record of delivery on past G8 aid promises" in light of recent concern over Canada's announcement that it will not fund abortion in its G8 initiative.

6 May 2010

Annual heart disease and stroke rates in China to rise up to 73% by 2030: Research

Annual heart disease and stroke rates in China will rise by up to 73 percent by 2030, given an aging population and other increased risk factors, without policies and prevention efforts aimed at controlling blood pressure and smoking, according to research from Columbia University Medical Center published in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

6 May 2010

Urgent changes needed to ‘prep’ doctors to care for aging America

Leading physician policy experts are calling for changes in medical education policy at multiple levels to ensure that doctors are prepared to treat the country's aging adult population.

6 May 2010

Researchers to identify rare genetic mutation to produce histamine against TS

A single, very unusual family with Tourette syndrome has led Yale School of Medicine researchers to identify a rare mutation in a gene that is required to produce histamine. The finding provides a new framework to understand many years of data on the role of histamine function in the brain and points to a potentially novel approach to treatment of tics and Tourette.

6 May 2010

CSI fiscal third-quarter revenue increases 9% to $16.5 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2010.

6 May 2010

Obesity epidemic may be flattening out - still much to be done

The prevalence of childhood obesity might be stabilising in developed countries, but there is still much to be done to combat this major threat to health, according to a Seminar published on Online First and in an upcoming issue of The Lancet.

6 May 2010

Bone marrow stem cells show promise in multiple sclerosis

A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease.

6 May 2010

GENFIT announces milestone as compound developed in partnership enters the clinic

GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces the achievement of a milestone in the therapeutic research collaboration with one of its strategic pharmaceutical partners.

6 May 2010

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.

6 May 2010

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2010, and provided an update with respect to the Company's key business initiatives.

6 May 2010

States face Medicaid losses, low-income patients struggle to find lasting health care sources

"Until now, stimulus money spared governors and state lawmakers from making some of the most brutal budget cuts. But with this lifeline running out, officials are looking at making significant cutbacks to public services, particularly schools and health programs.

6 May 2010

Bar-code eMAR combination of technologies reduce transcription, medication administration errors

Using bar-code technology with an electronic medication administration record (eMAR) substantially reduces transcription and medication administration errors, as well as potential drug-related adverse events, says a new study funded by HHS' Agency for Healthcare Research and Quality. The study is published in the May 6 issue of the New England Journal of Medicine.

6 May 2010

Medical News

Social changes spawn massive resurgence of syphilis in China

Advocates ask donor nations, African Governments to maintain health commitments as WEF on Africa starts

Cohera Medical reports top-line results from Tissuglu clinical trial

Sermo Category Report: About 30% of patients suffer from depression

Pharmasset reports net loss of $16.1 million for fiscal second-quarter 2010

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

FiatLux Imaging extends availability of free medical software

RayBiotech announces biomarker grant winners

Opinions: G8's track record; Maternal, child health; Chan on N. Korea; USAID, DDT in Haiti

Annual heart disease and stroke rates in China to rise up to 73% by 2030: Research

Urgent changes needed to ‘prep’ doctors to care for aging America

Researchers to identify rare genetic mutation to produce histamine against TS

CSI fiscal third-quarter revenue increases 9% to $16.5 million

Obesity epidemic may be flattening out - still much to be done

Bone marrow stem cells show promise in multiple sclerosis

GENFIT announces milestone as compound developed in partnership enters the clinic

ThromboGenics, BioInvent International report positive results from Phase II trial of TB-402 for VTE

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

States face Medicaid losses, low-income patients struggle to find lasting health care sources

Bar-code eMAR combination of technologies reduce transcription, medication administration errors

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News